EpiCast Report: Supportive Care in Oncology – Epidemiology Forecast to 2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cancer is a broad term for a group of diseases characterized by uncontrolled cell proliferation. Worldwide, it is estimated that 14 million new cases of cancer are diagnosed each year, and 30–50% of those cases are preventable (WHO, 2017). Cancer is the second leading cause of death worldwide, with more than eight million deaths caused by cancer in 2015 (WHO, 2017).
GlobalData epidemiologists provide the number of diagnosed incident cases of all cancer treated with chemotherapy and the number of diagnosed incident cases of chemotherapy-treated cancers that develop associated conditions (neutropenia, anemia, oral mucositis, nausea and vomiting, and cachexia). GlobalData epidemiologists also provide the number of diagnosed incident cases of prostate, breast, and lung cancers, and those that progress to bone metastasis. To forecast the diagnosed incident and the five-year diagnosed prevalent cases of all cancer in the 7MM, GlobalData epidemiologists selected reputable international cancer databases and nationally representative, population-based studies that provided the diagnosed incidence or relative survival rates for all cancer in the 7MM.
In 2016, there were 933,412 diagnosed incident cases of all cancer receiving chemotherapy treatment in men and women, ages 18 years and older, in the 7MM. Combination therapy was more common, with 75.8% of cases receiving chemotherapy in conjunction with surgery, radiation, or both. The remaining cases, 24.2%, received chemotherapy alone. Of those receiving chemotherapy, anemia and nausea and vomiting were the most common conditions resulting from the treatment. In 2016, there were 809,204 cases of chemotherapy-induced anemia and 746,730 cases of chemotherapy-induced nausea and vomiting in the 7MM.
Scope
The Supportive Care in Oncology EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of supportive care in oncology in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
This report also includes a 10-year epidemiological forecast for the following segmentations in ages 18 years and older across the 7MM: diagnosed incident cases of all cancer; five-year diagnosed prevalent cases of all cancer; diagnosed incident cases of all cancer treated with chemotherapy; diagnosed incident cases all cancer treated with chemotherapy with chemotherapy induced condition (neutropenia, anemia, oral mucositis, nausea and vomiting, and cachexia); diagnosed incident cases of prostate cancer (men ages 35 years and older); diagnosed incident cases of breast cancer (women ages 20 years and older); diagnosed incident cases of lung cancer (men and women ages 20 years and older); diagnosed incident cases of prostate, breast, and lung cancer that metastasize to bone.
The supportive care in oncology epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The Supportive Care in Oncology EpiCast series will allow you to:
Develop business strategies by understanding the trends shaping and driving the global oncology and chemotherapy treatment market.
Quantify patient populations in the global oncology and chemotherapy treatment market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for chemotherapy induced conditions therapeutics in each of the markets covered.
Understand magnitude of chemotherapy induced conditions.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.